Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:5 Issue:2 Number:3 ISSN#:2563-5476
ACE Report #9415
Ace Report Cover Arthroplasty

Erythropoietin reduces the risk of exposure to allogeneic blood transfusion in THA and TKA

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.

Vox Sang. 2016 Oct;111(3):219-225

Contributing Authors: VM Voorn A van der Hout C So-Osman TP Vliet Vlieland RG Nelissen ME van den Akker-van Marle A Dahan PJ Marang-van de Mheen L van Bodegom-Vos

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seven randomized controlled trials were included in this systematic review and meta-analysis to determine the effectiveness of erythropoietin in reducing the risk of exposure to allogenic blood transfusions in patients undergoing total hip and knee arthroplasty procedures. Outcomes assessed were the incidence of allogeneic blood transfusion, units of allogeneic blood transfused, the incidence of a...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.